| Issue Date | Title | Author(s) |
| 2022 | Downregulation of miR29b-2 is associated with hypertrophic scarring | Harmanci, D.; Kocak, A.; Demirdover, C.; Akdoğan, Gül |
| 2017 | Fibrosis modulation in scleroderma by epigallocatechin-3-gallate | Kocak, A.; Harmanci, D.; Birlik, M.; Sarioglu, S.; Yilmaz, O.; Cavdar, Z.; Akdoğan, Gül |
| 2018 | MOLECULAR MECHANISMS MEDIATING ANTIOXIDANT EFFECT OF EPIGALLOCATECHIN-3-GALLATE IN EXPERIMENTAL SCLERODERMA MODEL | Kocak, A.; Harmanci, D.; Birlik, M.; Guner, G. |
| 2021 | Possible effects of miR29a downregulation on keloid scar formation | Harmanci, D.; Kocak, A.; Demirdover, C. |
| 2017 | The presence of miR-29 family in skin hypertrophic scars and normal skin | Karagulle, D. Harmanci; Kocak, A.; Demirdover, C.; Lebe, B.; Akdoğan, Gül |
| 2017 | PROTECTIVE EFFECTS OF EPIGALLOCATECHIN 3 GALLATE ON FIBROSIS IN SCLERODERMA MODEL | Kocak, A.; Harmanci, D.; Birlik, M.; Sarioglu, S.; Akdoğan, Gül |
| 2022 | A training strategy from a research problem to a collaborative research environment and to building an innovation culture | Harmanci, D.; Uygun, Z. O.; Kocak, A.; Demirdover, C.; Sagin, F.; Akdoğan, Gül |
| 2018 | VITAMIN D AND VITAMIN D RECEPTOR IN PATIENTS WITH SCLERODERMA SUBTYPES | Kocak, A.; Harmanci, D.; Birlik, M.; Guner, G. |
